← Back to Volume 2, Issue 1

Application of Individual Case Management Nursing Model in Blood Lipid Management of Patients with Coronary Heart Disease

Zheng Xie, Yanqiu Xie
Vol.2, No.1, pp.140-145, 2024 DOI: 10.62051/ijphmr.v2n1.17 August 29, 2024
Download PDF
Abstract: Objective: To explore the effect of the case management nursing model on lipid management in patients with coronary heart disease. Methods: Coronary heart disease patients admitted to the cardiology department of a tertiary hospital in Henan Province from April 2023 to March 2024 were randomly divided into a conventional care group and a case management group. The case management model was implemented, and a 3-month follow-up was conducted. Data were collected and analyzed. Results: There were no statistically significant differences in baseline data between the two groups. After 3 months of case management, the case management group showed better medication adherence, greater reductions in lipid levels, and higher lipid control rates. Conclusion: The case management nursing model can improve medication adherence and lipid control rates in patients with coronary heart disease.
Keywords: Case management model, Coronary heart disease, Hyperlipidemia, Medication adherence
APA Citation: Zheng Xie, Yanqiu Xie (2024). Application of Individual Case Management Nursing Model in Blood Lipid Management of Patients with Coronary Heart Disease. International Journal of Public Health and Medical Research, 2(1), 140-145. https://doi.org/10.62051/ijphmr.v2n1.17

References

  1. Zhu Junren, Gao Runlin, Zhao Shuiping, et al. Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (2016 revised edition) [J]. Chinese Journal of Circulation, 2016, 31(10): 937-953. DOI: 10.3969/j.issn.1000-3614.2016.10.001
  2. Andrew M, Dongfeng G, Dong Z, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. [J]. Circulation. Cardiovascular quality and outcomes, 2010, 3 (3). DOI:10.1161/CIRCOUTCOMES.109.910711
  3. Gitt A K, Lautsch D, Ferrières J, et al. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II [J]. Atherosclerosis, 2017, 266:158-166. DOI:10.1016/j.atherosclerosis. 2017.08.013
  4. Low W C, Hess C N, Hiatt W R, et al. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations [J]. Circulation, 2016, 133(24):2459-2502. DOI:10.1161/CIRCULATIONAHA.116.022194
  5. Ji H, Chen R, Huang Y, et al. Effect of simulation education and case management on glycemic control in type 2 diabetes [J]. Diabetes Metab Res Rev, 2019, 35(3):e3112. DOI:10.1002/dmrr. 3112
  6. Takeda A, Martin N, Taylor R S, et al. Disease management interventions for heart failure [J]. Cochrane Database Syst Rev, 2019, 1(1):D2752. DOI:10.1002/14651858.CD002752.pub4
  7. Hudon C, Chouinard M C, Dubois M F, et al. Case Management in Primary Care for Frequent Users of Health Care Services: A Mixed Methods Study [J]. Ann Fam Med, 2018, 16(3):232-239. DOI:10.1370/afm.2233
  8. Egede L E, Williams J S, Voronca D C, et al. Randomized Controlled Trial of Technology-Assisted Case Management in Low Income Adults with Type 2 Diabetes [J]. Diabetes Technol Ther, 2017, 19(8):476-482. DOI:10.1089/dia.2017.0006
  9. Morisky D E, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting [J]. J Clin Hypertens (Greenwich), 2008, 10(5):348-354. DOI:10.1111/j.1751-7176.2008.07572.x
  10. Chiang C Y, Choi K C, Ho K M, et al. Effectiveness of nurse-led patient-centered care behavioral risk modification on secondary prevention of coronary heart disease: A systematic review [J]. Int J Nurs Stud, 2018, 84:28-39. DOI:10.1016/j.ijnurstu.2018.04.012
  11. Satija A, Bhupathiraju S N, Spiegelman D, et al. Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults [J]. J Am Coll Cardiol, 2017, 70(4):411-422. DOI:10.1016/j.jacc.2017.05.047
  12. Wood D A, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial [J]. Lancet, 2008, 371(9629):1999-2012. DOI:10.1016/S0140-6736(08)60868-5
  13. Cannon C P, Khan I, Klimchak A C, et al. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease [J]. JAMA Cardiol, 2017, 2(9):959-966. DOI:10.1001/jamacardio.2017.2289
  14. Daida H, Dohi T, Fukushima Y, et al. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials [J]. J Atheroscler Thromb, 2019, 26(7):592-600. DOI:10.5551/jat.48603
  15. Goldberg A C, Leiter L A, Stroes E, et al. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial [J]. JAMA, 2019, 322(18):1780-1788. DOI:10.1001/jama.2019.20661